> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Golfer James Hahn Promoting Licart
- URL: https://www.fdaweb.com/golfer-james-hahn-promoting-licart/
- Published: 2022-04-13T12:00:00.000Z
- Updated: 2026-09-14T17:40:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151587

Pro golfer **James Hahn** has signed on with IBSA Pharma to promote Licart (diclofenac epolamine), the company’s newest topical pain product. A company [statement](https://www.businesswire.com/news/home/20220413005221/en/?ref=fdaweb.com) says Licart is the first and only once-a-day topical non-steroidal anti-inflammatory drug indicated to treat acute pain due to minor strains, sprains, and contusions.

As part of the partnership, IBSA says, Hahn will wear the Licart logo on his clothing and appear on social media and at events to promote the brand. IBSA says Hahn is both a spokesperson and a Licart patient.